{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T03:21:49Z","timestamp":1768792909749,"version":"3.49.0"},"reference-count":99,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Wroc\u0142aw Medical University"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Heart failure (HF) affects 64 million people worldwide and is one of the most prevalent causes of hospitalization in adults. Infection is believed to be one of the potential triggers that may facilitate HF decompensation and the need for hospitalization. Therefore, it seems crucial to safeguard against such a situation. Vaccinations seem to be a very reasonable option. However, this remains an underutilized solution among HF patients. This review investigates the impact of available vaccinations, including influenza, COVID-19, pneumococcal, and RSV, on prognosis in specific HF populations only, as there are pathophysiological reasons to believe that this population of patients may benefit the most from the intervention. It will provide information about the safety profile of these vaccines and summarize the available evidence on their impact on hard clinical outcomes. In summary, this article will discuss the impact of preventive vaccinations against seasonal infections in the HF population.<\/jats:p>","DOI":"10.3390\/vaccines12121321","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T04:02:18Z","timestamp":1732593738000},"page":"1321","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Impact of Vaccinations Against Respiratory Infections on the Prognosis in Heart Failure Patients"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9617-0273","authenticated-orcid":false,"given":"Berenika","family":"Jankowiak","sequence":"first","affiliation":[{"name":"Institute of Heart Diseases, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Wleklik","sequence":"additional","affiliation":[{"name":"Division of Research Methodology, Department of Nursing, Faculty of Nursing and Midwifery, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Rosiek-Biegus","sequence":"additional","affiliation":[{"name":"Institute of Internal Diseases, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.15420\/cfr.2023.05","article-title":"Global Public Health Burden of Heart Failure: An Updated Review","volume":"9","author":"Shahim","year":"2023","journal-title":"Card. Fail. Rev."},{"key":"ref_2","first-page":"115","article-title":"Heart failure in the elderly","volume":"13","author":"Alfonso","year":"2016","journal-title":"J. Geriatr. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/ehf2.13823","article-title":"Trends and characteristics of hospitalizations for heart failure in the United States from 2004 to 2018","volume":"9","author":"Salah","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1002\/ehf2.13921","article-title":"Five-year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort","volume":"9","author":"Chen","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_5","first-page":"744","article-title":"Multi-organ dysfunction\/injury on admission identifies acute heart failure patients at high risk of poor outcome","volume":"21","author":"Sokolski","year":"2018","journal-title":"Eur. J. Heart Fail."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jchf.2022.05.013","article-title":"Pathophysiologic Processes and Novel Biomarkers Associated with Congestion in Heart Failure","volume":"10","author":"Pandhi","year":"2022","journal-title":"JACC Heart Fail."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.hfc.2021.06.001","article-title":"Pathophysiology of Advanced Heart Failure: What Knowledge Is Needed for Clinical Management?","volume":"17","author":"Biegus","year":"2021","journal-title":"Heart Fail. Clin."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Thapa, A., Kang, J., Chung, M.L., Wu, J.-R., Latimer, A., Lennie, T.A., Lin, C.-Y., Thompson, J.H., Cha, G., and Moser, D.K. (2024). Perceived Control, Functional Status, Depressive Symptoms, and Anxiety: Mediating and Moderating Influences on Health-Related Quality of Life in Patients With Heart Failure. J. Cardiovasc. Nurs.","DOI":"10.1097\/JCN.0000000000001100"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ehf2.14480","article-title":"Cardiovascular events, mortality, early retirement and costs in >50,000 persons with chronic heart failure in Sweden","volume":"11","author":"Carlsson","year":"2023","journal-title":"ESC Heart Fail."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/ehf2.14245","article-title":"Cardiovascular vs. non-cardiovascular deaths after heart failure hospitalization in young, older, and very old patients","volume":"10","author":"Nakamaru","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/ehf2.13900","article-title":"Burden of hospitalizations in newly diagnosed heart failure patients in Poland: Real world population based study in years 2013\u20132019","volume":"9","author":"Leszek","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1002\/ehf2.14103","article-title":"Ten year age- and sex-specific temporal trends in incidence and prevalence of heart failure in V\u00e4stra G\u00f6taland, Sweden","volume":"9","author":"Wideqvist","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41569-020-0413-9","article-title":"COVID-19 and cardiovascular disease: From basic mechanisms to clinical perspectives","volume":"17","author":"Nishiga","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000493572","article-title":"Beneficial Effects of Vaccination on Cardiovascular Events: Myocardial Infarction, Stroke, Heart Failure","volume":"141","author":"Fountoulaki","year":"2018","journal-title":"Cardiology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/jama.2022.12992","article-title":"Association Between Vaccination and Acute Myocardial Infarction and Ischemic Stroke After COVID-19 Infection","volume":"328","author":"Kim","year":"2022","journal-title":"JAMA"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Whiteley, W.N., Ip, S., Cooper, J.A., Bolton, T., Keene, S., Walker, V., Denholm, R., Akbari, A., Omigie, E., and Hollings, S. (2022). Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, or thrombocytopenic events: A population-based cohort study of 46 million adults in England. PLoS Med., 19.","DOI":"10.1371\/journal.pmed.1003926"},{"key":"ref_18","first-page":"EVIDoa2300361","article-title":"Influenza Infection and Acute Myocardial Infarction","volume":"3","author":"Vaartjes","year":"2024","journal-title":"NEJM \u00c9vid."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1002\/ehf2.14126","article-title":"SARS-CoV-2-related Multisystem Inflammatory Syndrome in Adult complicated by myocarditis and cardiogenic shock","volume":"9","author":"Fierens","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1002\/ehf2.13791","article-title":"Myocarditis following mRNA COVID-19 vaccination: Call for endomyocardial biopsy","volume":"9","author":"Kiblboeck","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-020-0151-7","article-title":"Acute heart failure","volume":"6","author":"Arrigo","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ehf2.14163","article-title":"Kochi YOSACOI study Frailty interferes with the guideline-directed medical therapy in heart failure patients with reduced ejection fraction","volume":"10","author":"Hamada","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1002\/ehf2.14478","article-title":"The impact of gender and frailty on the outcome of older patients with functional mitral regurgitation","volume":"10","author":"Bruno","year":"2023","journal-title":"ESC Heart Fail."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/ehf2.14114","article-title":"The interaction between physical frailty and prognostic impact of heart failure medication in elderly patients","volume":"10","author":"Abe","year":"2023","journal-title":"ESC Heart Fail."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1002\/ehf2.14118","article-title":"Heart failure during the COVID-19 pandemic: Clinical, diagnostic, management, and organizational dilemmas","volume":"9","author":"Palazzuoli","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1093\/eurheartj\/ehn296","article-title":"Acute viral myocarditis","volume":"29","author":"Dennert","year":"2008","journal-title":"Eur. Heart J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s12272-017-0933-y","article-title":"Pneumonia and Streptococcus pneumoniae vaccine","volume":"40","author":"Kim","year":"2017","journal-title":"Arch. Pharmacal Res."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Alon, D., Stein, G.Y., Korenfeld, R., and Fuchs, S. (2013). Predictors and Outcomes of Infection-Related Hospital Admissions of Heart Failure Patients. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0072476"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e18080","DOI":"10.1016\/j.heliyon.2023.e18080","article-title":"Evaluation of vaccination coverage in heart failure patients in a tertiary center","volume":"9","author":"Maire","year":"2023","journal-title":"Heliyon"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.tim.2018.05.013","article-title":"Influenza Virus","volume":"26","author":"Hutchinson","year":"2018","journal-title":"Trends Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1038\/s41467-024-47862-9","article-title":"Seasonal antigenic prediction of influenza A H3N2 using machine learning","volume":"15","author":"Shah","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1002\/jmv.26990","article-title":"A brief review of influenza virus infection","volume":"93","author":"Javanian","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jchf.2018.10.011","article-title":"Effect of Influenza on Outcomes in Patients with Heart Failure","volume":"7","author":"Panhwar","year":"2019","journal-title":"JACC Heart Fail."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e1835","DOI":"10.1016\/S2214-109X(22)00432-6","article-title":"Influenza vaccine to reduce adverse vascular events in patients with heart failure: A multinational randomised, double-blind, placebo-controlled trial","volume":"10","author":"Loeb","year":"2022","journal-title":"Lancet Glob. Health"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"ofz159","DOI":"10.1093\/ofid\/ofz159","article-title":"The Effect of Influenza Vaccination on Mortality and Risk of Hospitalization in Patients with Heart Failure: A Systematic Review and Meta-analysis","volume":"6","author":"Poudel","year":"2019","journal-title":"Open Forum Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCULATIONAHA.118.036788","article-title":"Influenza Vaccine in Heart Failure","volume":"139","author":"Modin","year":"2019","journal-title":"Circulation"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/ejhf.14","article-title":"Influenza vaccine and survival in acute heart failure","volume":"16","author":"Kopel","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.amjcard.2020.05.019","article-title":"Influenza Vaccination and Outcome in Heart Failure","volume":"128","author":"Gotsman","year":"2020","journal-title":"Am. J. Cardiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jchf.2015.10.012","article-title":"Influenza Vaccination in Patients with Chronic Heart Failure","volume":"4","author":"Vardeny","year":"2015","journal-title":"JACC Heart Fail."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1016\/j.vaccine.2022.04.039","article-title":"Effectiveness of the influenza vaccine at reducing adverse events in patients with heart failure: A systematic review and meta-analysis","volume":"40","author":"Gupta","year":"2022","journal-title":"Vaccine"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jama.2020.23649","article-title":"Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients with High-risk Cardiovascular Disease","volume":"325","author":"Vardeny","year":"2021","journal-title":"JAMA"},{"key":"ref_42","unstructured":"OECD (2024, November 09). \u201cInfluenza Vaccination Rates\u201d (Indicator). Available online: https:\/\/www.oecd-ilibrary.org\/social-issues-migration-health\/influenza-vaccination-rates\/indicator\/english_e452582e-en."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/pds.3575","article-title":"Absence of associations between influenza vaccines and increased risks of seizures, Guillain\u2013Barr\u00e9 syndrome, encephalitis, or anaphylaxis in the 2012\u20132013 season","volume":"23","author":"Kawai","year":"2014","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_44","first-page":"31","article-title":"Delgado, Epidemiology and treatment of heart failure in Spain: The HF-PATHWAYS study","volume":"75","author":"Palacios","year":"2022","journal-title":"REC Interv. Cardiol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Sekiya, T., Ohno, M., Nomura, N., Handabile, C., Shingai, M., Jackson, D.C., Brown, L.E., and Kida, H. (2021). Selecting and Using the Appropriate Influenza Vaccine for Each Individual. Viruses, 13.","DOI":"10.3390\/v13060971"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Y\u00fcce, M., Filiztekin, E., and \u00d6zkaya, K.G. (2020). COVID-19 diagnosis\u2014A review of current methods. Biosens. Bioelectron., 172.","DOI":"10.1016\/j.bios.2020.112752"},{"key":"ref_47","first-page":"10","article-title":"Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)\/COVID-19 Detection","volume":"34","author":"Tali","year":"2021","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10741-020-10008-2","article-title":"Heart failure and COVID-19","volume":"26","author":"Bader","year":"2020","journal-title":"Heart Fail. Rev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/HCO.0000000000000832","article-title":"COVID-19 myocarditis and long-term heart failure sequelae","volume":"36","author":"Liu","year":"2020","journal-title":"Curr. Opin. Cardiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1002\/ejhf.2669","article-title":"Myocarditis following COVID-19 vaccine: Incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases","volume":"24","author":"Heidecker","year":"2022","journal-title":"Eur. J. Heart Fail."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Parenica, J., Benesova, K., Radvan, M., Sanca, O., Hlasensky, J., Lokaj, P., Ondrus, T., Helanova, K., Kala, P., and Dusek, L. (2022). COVID-19 vaccine booster significantly decreases the risk of intensive care unit hospitalization in heart failure patients during the Omicron variant wave: A population-based study. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.998842"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"248","DOI":"10.32074\/1591-951X-954","article-title":"COVID-19. Biology, pathophysiology, and immunology: A pathologist view","volume":"115","author":"Chilosi","year":"2023","journal-title":"Pathologica"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ccl.2022.03.001","article-title":"The Cardiovascular Manifestations of COVID-19","volume":"40","author":"Louis","year":"2022","journal-title":"Cardiol. Clin."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/ehf2.14295","article-title":"COVID-19-associated myocardial injury: A case report","volume":"10","author":"Tadokoro","year":"2023","journal-title":"ESC Heart Fail."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Urban, S., Fu\u0142ek, M., B\u0142aziak, M., Iwanek, G., Jura, M., Fu\u0142ek, K., Guzik, M., Garus, M., Gajewski, P., and Lewandowski, \u0141. (2022). COVID-19 Related Myocarditis in Adults: A Systematic Review of Case Reports. J. Clin. Med., 11.","DOI":"10.3390\/jcm11195519"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Hulscher, N., Hodkinson, R., Makis, W., and McCullough, P.A. (ESC Heart Fail., 2024). Autopsy findings in cases of fatal COVID-19 vaccine-induced myocarditis, ESC Heart Fail., Online ahead of print.","DOI":"10.1002\/ehf2.14680"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1002\/ehf2.13964","article-title":"Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: Results of an international multicentre registry","volume":"9","author":"Gimeno","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"ytac004","DOI":"10.1093\/ehjcr\/ytac004","article-title":"A report of two cases of myocarditis following mRNA coronavirus disease 2019 vaccination","volume":"6","author":"Bengel","year":"2022","journal-title":"Eur. Heart J. Case Rep."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"ytac191","DOI":"10.1093\/ehjcr\/ytac191","article-title":"Left ventricular outflow tract thrombus in a patient with COVID-19\u2014A ticking time bomb: A case report","volume":"6","author":"Muhammadzai","year":"2022","journal-title":"Eur. Heart J. Case Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"ytac061","DOI":"10.1093\/ehjcr\/ytac061","article-title":"Coronavirus disease 2019-associated coronary endotheliitis and thrombotic microangiopathy causing cardiogenic shock: A case report","volume":"6","author":"Valiton","year":"2022","journal-title":"Eur. Heart J. Case Rep."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1002\/ejhf.1990","article-title":"Heart failure in COVID-19 patients: Prevalence, incidence and prognostic implications","volume":"22","author":"Rey","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/ejhf.1925","article-title":"Temporal trends in decompensated heart failure and outcomes during COVID-19: A multisite report from heart failure referral centres in London","volume":"22","author":"Bromage","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1002\/ejhf.2044","article-title":"In-hospital care in acute heart failure during the COVID-19 pandemic: Insights from the German-wide Helios hospital network","volume":"22","author":"Hohenstein","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/ejhf.1915","article-title":"Management of heart failure patients with COVID-19: A joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology","volume":"22","author":"Zhang","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/ejhf.1871","article-title":"COVID-19 and heart failure: From infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease","volume":"22","author":"Tomasoni","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.amjmed.2020.08.043","article-title":"Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on Acute Admissions at the Emergency and Cardiology Departments Across Europe","volume":"134","author":"Sokolski","year":"2021","journal-title":"Am. J. Med."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Gajewski, P., B\u0142aziak, M., Urban, S., Garus, M., Braunschweig, F., Caldeira, D., Gawor, A., Greenwood, J.P., Guzik, M., and Halfwerk, F.R. (2023). Sex-stratified patterns of emergency cardiovascular admissions prior and during the COVID-19 pandemic. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-44400-3"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"mzab029","DOI":"10.1093\/intqhc\/mzab029","article-title":"Impact of a prolonged COVID-19 lockdown on patterns of admission, mortality and performance indicators in a cardiovascular intensive care unit","volume":"33","author":"Szarfer","year":"2021","journal-title":"Int. J. Qual. Health Care"},{"key":"ref_69","first-page":"e010617","article-title":"Risk of Worsening Heart Failure and All-Cause Mortality Following COVID-19 Vaccination in Patients with Heart Failure: A Nationwide Real-World Safety Study","volume":"16","author":"Michalik","year":"2023","journal-title":"Circ. Heart Fail."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"517","DOI":"10.15585\/mmwr.mm7114e1","article-title":"Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination\u2014PCORnet, United States, January 2021\u2013January 2022","volume":"71","author":"Block","year":"2022","journal-title":"Mmwr-Morb. Mortal. Wkly. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1002\/ehf2.13962","article-title":"Fulminant necrotizing eosinophilic myocarditis after COVID-19 vaccination survived with mechanical circulatory support","volume":"9","author":"Kimura","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1002\/ehf2.13971","article-title":"Cardiac involvement in patients recovering from Delta Variant of COVID-19: A prospective multi-parametric MRI study","volume":"9","author":"Zhang","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"ytab534","DOI":"10.1093\/ehjcr\/ytab534","article-title":"Case report of acute myocarditis after administration of coronavirus disease 2019 vaccine in Japan","volume":"6","author":"Ohnishi","year":"2022","journal-title":"Eur. Heart J. Case Rep."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"ytac012","DOI":"10.1093\/ehjcr\/ytac012","article-title":"Effusive\u2013constrictive pericarditis after the second dose of BNT162b2 vaccine (Comirnaty): A case report","volume":"6","author":"Viani","year":"2022","journal-title":"Eur. Heart J. Case Rep."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Hrycek, E., Walawska-Hrycek, A., Milewski, K., Nowakowski, P., Buszman, P., and \u017burakowski, A. (2024). The Influence of SARS-CoV-2 Vaccination on the Mortality and Outcomes of Patients with Both Myocardial Infarction and COVID-19. Vaccines, 12.","DOI":"10.3390\/vaccines12090983"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"126305","DOI":"10.1016\/j.vaccine.2024.126305","article-title":"Association of SARS-CoV-2 immunoserology and vaccination status with myocardial infarction severity and outcome","volume":"42","author":"Blasco","year":"2024","journal-title":"Vaccine"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1056\/NEJMoa2110475","article-title":"Safety of the BNT162b2 mRNA COVID-19 Vaccine in a Nationwide Setting","volume":"385","author":"Barda","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"683","DOI":"10.23736\/S0026-4806.23.08509-9","article-title":"Role of available COVID-19 vaccines in reducing deaths and perspective for next generation vaccines and therapies to counter emerging viral variants: An update","volume":"114","author":"Wahid","year":"2023","journal-title":"Minerva Medica"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Xu, K., Wang, Z., Qin, M., Gao, Y., Luo, N., Xie, W., Zou, Y., Wang, J., and Ma, X. (2023). A systematic review and meta-analysis of the effectiveness and safety of COVID-19 vaccination in older adults. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1113156"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1056\/NEJMoa2110737","article-title":"Myocarditis after COVID-19 vaccination in a large health care organization","volume":"385","author":"Witberg","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.2021.24110","article-title":"Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021","volume":"327","author":"Oster","year":"2022","journal-title":"JAMA"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1001\/jamaneurol.2021.3619","article-title":"Characteristics and Outcomes of Patients with Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine\u2013Induced Immune Thrombotic Thrombocytopenia","volume":"78","author":"Poli","year":"2021","journal-title":"JAMA Neurol."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Xu, Y., Li, H., Santosa, A., Wettermark, B., Fall, T., Bj\u00f6rk, J., B\u00f6rjesson, M., Gissl\u00e9n, M., and Nyberg, F. (2024). Cardiovascular events following coronavirus disease 2019 vaccination in adults: A nationwide Swedish study. Eur. Heart J., ehae639.","DOI":"10.1093\/eurheartj\/ehae639"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/microbiolspec.GPP3-0028-2018","article-title":"Pneumococcal Vaccines","volume":"7","author":"Briles","year":"2019","journal-title":"Microbiol. Spectr."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/jama.2014.18229","article-title":"Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease","volume":"313","author":"Alvarez","year":"2015","journal-title":"JAMA"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/cid\/cix164","article-title":"SIXTUS (Thrombosis-Related Extrapulmonary Outcomes in Pneumonia) Study Group. Cardio- vascular complications and short-term mortality risk in communi- ty-acquired pneumonia","volume":"64","author":"Violi","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.vaccine.2017.11.078","article-title":"Cardioprotective effect of influenza and pneumococcal vaccination in patients with cardiovascular diseases","volume":"36","author":"Ciszewski","year":"2018","journal-title":"Vaccine"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ijid.2020.07.038","article-title":"The protective effect of pneumococcal vaccination on cardiovascular disease in adults: A systematic review and meta-analysis","volume":"99","author":"Marra","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/ehjqcco\/qcaa030","article-title":"Pneumococcal vaccination in adults at very high risk or with established cardiovascular disease: Systematic review and meta-analysis","volume":"7","author":"Antunes","year":"2020","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jchf.2018.04.012","article-title":"Hernandez\u2014Vaccination Trends in Patients with Heart Failure: Insights from Get with The Guidelines","volume":"6","author":"Bhatt","year":"2018","journal-title":"JACC Heart Fail."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1086\/649839","article-title":"Safety and Antibody Response, Including Antibody Persistence for 5 Years, after Primary Vaccination or Revaccination with Pneumococcal Polysaccharide Vaccine in Middle-Aged and Older Adults","volume":"201","author":"Musher","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"ofy100","DOI":"10.1093\/ofid\/ofy100","article-title":"Pneumococcal Conjugate Vaccine Safety in Elderly Adults","volume":"5","author":"Tseng","year":"2018","journal-title":"Open Forum Infect. Dis."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"404","DOI":"10.14336\/AD.2018.0512","article-title":"Efficacy and Safety of the Pneumococcal Conjugate-13 Valent Vaccine in Adults","volume":"10","author":"Marra","year":"2019","journal-title":"Aging Dis."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa043951","article-title":"Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults","volume":"352","author":"Falsey","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1001\/jamainternmed.2024.0212","article-title":"Acute Cardiac Events in Hospitalized Older Adults with Respiratory Syncytial Virus Infection","volume":"184","author":"Woodruff","year":"2024","journal-title":"JAMA Intern. Med."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Anderson, E.J., Tippett, A., Begier, E., Gibson, T., Ess, G., Patel, V., Taylor, M., Reese, O., Salazar, L., and Jadhao, S. (2024). Relative Contribution of Diagnostic Testing to the Diagnosis of Respiratory Syncytial Virus in Hospitalized Adults in the United States. J. Infect. Dis., jiae346.","DOI":"10.1093\/infdis\/jiae346"},{"key":"ref_97","first-page":"1574","article-title":"Respiratory Syncytial Virus and Associations with Cardiovascular Disease in Adults","volume":"71","author":"Ivey","year":"2018","journal-title":"Circ."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cmi.2016.11.014","article-title":"Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in France","volume":"23","author":"Loubet","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1016\/j.vaccine.2024.03.060","article-title":"The early safety profile of simultaneous vaccination against influenza and Respiratory Syncytial Virus (RSV) in patients with high-risk heart failure","volume":"42","author":"Biegus","year":"2024","journal-title":"Vaccine"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/12\/1321\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:39:31Z","timestamp":1760114371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/12\/1321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,26]]},"references-count":99,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["vaccines12121321"],"URL":"https:\/\/doi.org\/10.3390\/vaccines12121321","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,26]]}}}